Rong Na, Yao Jiaying, Quan Hui, Wu Jing, Zhao Binbin, Peng Wanjun, Yang Hekai, Zhang Gengxin, Ding Xiaoyue, Wei Xiaohui, Liu Jiangning
NHC Key Laboratory of Human Disease Comparative Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
Annoroad Gene Technology (Beijing) Co., Ltd, Beijing, China.
Virulence. 2025 Dec;16(1):2548931. doi: 10.1080/21505594.2025.2548931. Epub 2025 Aug 28.
The markedly reduced pathogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron variant in comparison to earlier strains has raised critical questions regarding its underlying mechanisms. To elucidate the host immune responses driving these differences, we performed single-cell transcriptomic profiling of lung and blood samples from human angiotensin-converting enzyme 2 (hACE2) transgenic mice infected with either the SARS-CoV-2 prototype strain or the Omicron BA.1 variant at 5 days post-inoculation. Both strains induced a reduction in lung cell numbers, with capillary endothelial cells showing the highest number of differentially expressed genes (DEGs). Shared transcriptional responses included upregulation of chemokine (e.g. , , ) and IL-17 signaling pathways. Notably, Omicron BA.1 infection resulted in downregulation of , a key gene involved in oxidative stress responses. Genes associated with neutrophil granules and pro-inflammatory functions (, , ) were also downregulated, whereas wound healing pathways were upregulated in immature neutrophils. Additionally, Omicron BA.1 altered gene expression associated with neutrophil migration from blood to lung, and decreased the activation of cell chemotaxis, cytokine-mediated signaling, IL-17 and NF-κB pathways in pro-inflammatory monocytes and pulmonary interstitial macrophages. These findings highlight distinct immunological signatures contributing to the attenuated pathogenicity of Omicron BA.1, particularly through the modulation of neutrophil and monocyte-macrophage responses.
与早期毒株相比,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变体的致病性显著降低,这引发了关于其潜在机制的关键问题。为了阐明导致这些差异的宿主免疫反应,我们对感染了SARS-CoV-2原型毒株或奥密克戎BA.1变体的人血管紧张素转换酶2(hACE2)转基因小鼠在接种后5天的肺和血液样本进行了单细胞转录组分析。两种毒株均导致肺细胞数量减少,其中毛细血管内皮细胞显示出最高数量的差异表达基因(DEG)。共同的转录反应包括趋化因子(如 、 、 )和IL-17信号通路的上调。值得注意的是,奥密克戎BA.1感染导致参与氧化应激反应的关键基因 的下调。与中性粒细胞颗粒和促炎功能相关的基因( 、 、 )也下调,而未成熟中性粒细胞中的伤口愈合通路上调。此外,奥密克戎BA.1改变了与中性粒细胞从血液迁移到肺相关的基因表达,并降低了促炎单核细胞和肺间质巨噬细胞中细胞趋化性、细胞因子介导的信号传导、IL-17和NF-κB通路的激活。这些发现突出了导致奥密克戎BA.1致病性减弱的独特免疫特征,特别是通过对中性粒细胞和单核细胞-巨噬细胞反应的调节。